Keyphrases
2-year Survival
75%
Active Follow-up
25%
Adjuvant Therapy
25%
Advanced Stage
25%
Age at Diagnosis
25%
Breast Cancer Patients
100%
Confidence Interval
75%
Cox Regression Analysis
25%
Estrogen
25%
Female Breast Cancer
25%
Hazard Ratio
100%
HER2 Overexpression
25%
Histopathological Features
25%
Hormone Receptor
25%
Hormone Receptor-negative
25%
Hormone Receptor-positive Disease
50%
Limited Access
25%
Lymph Node Positive
25%
Neoadjuvant Endocrine Therapy
25%
Overall Survival
25%
Pathology Services
25%
Positive Lymph Nodes
50%
Progesterone Receptor Expression
25%
Rural Ethiopia
100%
Rural Setting
25%
Survival Probability
25%
Triple-negative Disease
25%
Tumor
100%
Western Ethiopia
50%
INIS
breasts
100%
cancer
100%
comparative evaluations
16%
dies
8%
diseases
41%
estrogens
8%
ethiopia
100%
females
8%
hazards
33%
hormones
41%
lymph nodes
25%
pathology
16%
patients
100%
probability
8%
progesterone
8%
receptors
41%
regression analysis
8%
surgery
16%
testing
8%
therapy
8%
tumors
33%
Medicine and Dentistry
Adjuvant Therapy
20%
Breast Cancer
100%
Disease
100%
Hazard Ratio
80%
Hormone Receptor
80%
Hormone Therapy
20%
Lenabasum
20%
Lymph Node
60%
Neoplasm
80%
Patient Referral
20%
Progesterone Receptor
20%
Proportional Hazards Model
20%
Prospective Study
20%
Receptor Expression
20%
Survival Rate
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Disease
100%
Hormone Cancer Therapy
20%
Hormone Receptor
80%
Lenabasum
20%
Neoplasm
80%
Progesterone Receptor
20%
Prospective Study
20%
Survival Rate
20%
Biochemistry, Genetics and Molecular Biology
Hormone Receptor
100%
Progesterone Receptor
25%
Prospective Study
25%
Survival Rate
25%